- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-12-0015952

Omics Nextgen Laboratories Private Limited
About Omics Nextgen Laboratories Private Limited
Data last updated:
Omics Nextgen Laboratories Private Limited is a private limited company based in Palakol(Mdl), Andhra Pradesh, India. It operates in the specialized hospitals segment of the healthcare sector. It was incorporated on 29 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U85110AP2021PTC118398.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Murali Krishna Rao Kommula and Madhu Babu Pulagam.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Palakol(Mdl), Andhra Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹60.38 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹3.54 Lakh (net margin 5.9%) and EBITDA of ₹26.42 Lakh (EBITDA margin 43.8%).
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Omics Nextgen Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-12-0015952).
Company details
Recognitions & Rankings of Omics Nextgen Laboratories
Contact details
Omics Nextgen Laboratories Private Limited's registered office is in Palakol(Mdl), Andhra Pradesh.
- Registered Address11 – 2 – 19/A1, Sri Vijaya Laboratory, Palakol(Mdl), Andhra Pradesh, India – 534260
- IndustryHealthcare, Specialized Hospitals, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Omics Nextgen Laboratories is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Omics Nextgen Laboratories Private Limited, buy the company report.
Financials of Omics Nextgen Laboratories Private Limited
FY 2025 filings availableOmics Nextgen Laboratories Private Limited reported revenue of ₹60.38 Lakh (down 36% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 36% in the latest year. EBITDA rose 316% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹26.42 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹3.54 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 43.8% | ||
| Net Profit Margin | 5.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Omics Nextgen Laboratories Private Limited, buy the company report.
Board of directors of Omics Nextgen Laboratories Private Limited
Omics Nextgen Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishna Rao Kommula | Director | 29 May 2021 | 5 Years 4 Months | Current |
| Madhu Babu Pulagam Also directs: Drdiagnomics Private Limited | Director | 29 May 2021 | 5 Years 4 Months | Current |
Peer comparison
Omics Nextgen Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hardev Lifecare Services Private Limited | ₹60.99 Lakh (FY 2025) | Delhi, India | ||||
| Ar's Gurugram Gastro & Liver Private Limited | ₹60.64 Lakh (FY 2024) | Gurgaon, Haryana, India | ||||
| Dishakritya Foundation | ₹60.6 Lakh (FY 2025) | 5749.0% | Kolkata, West Bengal, India | |||
| Dr. Nidhi Skin Rehab Solutions Private Limited | ₹60.57 Lakh (FY 2024) | 7.0% | New Delhi, Delhi, India | |||
| Kripa Health Care Private Limited | ₹60.49 Lakh (FY 2025) | 108.0% | Patna, Bihar, India | |||
| Omics Nextgen Laboratories Private Limitedthis company | ₹60.38 Lakh (FY 2024) | ₹3.54 Lakh | 5.9% | -36.0% | Palakol(Mdl), Andhra Pradesh, India | |
| Cudure Healthcare Private Limited | ₹60.28 Lakh (FY 2025) | 6.0% | Vishakapatanam, Andhra Pradesh, India | |||
| Pdra Imaging Private Limited | ₹60.26 Lakh (FY 2025) | 63.0% | Mumbai, Maharashtra, India | |||
| Zoys Healthcare Services Private Limited | ₹60.13 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Srujan Meditech Private Limited | ₹60.09 Lakh (FY 2025) | 273.0% | Ahmedabad, Gujarat, India | |||
| Bawa Hospital Private Limited | ₹59.98 Lakh (FY 2024) | 32.0% | Ludhiana, Punjab, India |
To see the full peer comparison of Omics Nextgen Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101163574 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Omics Nextgen Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Omics Nextgen Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Omics Nextgen Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Omics Nextgen Laboratories Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Madhu Babu Pulagam was appointed as Director on 29 May 2021.
Frequently asked questions
Omics Nextgen Laboratories is an active private limited company based in Palakol(Mdl), Andhra Pradesh, India. The company works in specialized hospitals, within the healthcare industry. It was incorporated on 29 May 2021 (5+ years old) and is registered under CIN U85110AP2021PTC118398.
Omics Nextgen Laboratories has 2 current directors:
- Murali Krishna Rao Kommula - Director
- Madhu Babu Pulagam - Director
The latest financial statements of Omics Nextgen Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Omics Nextgen Laboratories is U85110AP2021PTC118398. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omics Nextgen Laboratories was incorporated on 29 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Omics Nextgen Laboratories by revenue are Hardev Lifecare Services Private Limited, Ar's Gurugram Gastro & Liver Private Limited, Dishakritya Foundation, Dr. Nidhi Skin Rehab Solutions Private Limited, Kripa Health Care Private Limited and 5 more, all in the same principal business activity (human health activities).
Madhu Babu Pulagam was appointed as Director on 29 May 2021. Murali Krishna Rao Kommula was appointed as Director on 29 May 2021.
Yes, Omics Nextgen Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-12-0015952).
The registered office of Omics Nextgen Laboratories is at 11 – 2 – 19A1, Sri Vijaya Laboratory, PalakolMdl, Andhra Pradesh, India – 534260.
Omics Nextgen Laboratories operates in the healthcare industry, in the specialized hospitals segment.
Omics Nextgen Laboratories has open charges of ₹50 Lakh and no satisfied charges on record as per latest MCA filings.